Inputs and outputs of poly(ADP-ribosyl)ation: Relevance to oxidative stress

Redox Biology

Volumn 2, Issue 1, 2014, Pages 978-982

  Hegedus, Csaba ^a   Virág, László ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b MTA de Cell Biology and Signaling Research Group   (Hungary)

Author keywords

Apoptosis; Cell death; Necroptosis; Oxidative stress; PARP1; Poly(ADP ribosyl)ation

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PARP1 PROTEIN, HUMAN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); ARSENIC TRIOXIDE; COLECALCIFEROL; FLAVONE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PURINE DERIVATIVE; RETINOL; TETRACYCLINE DERIVATIVE; UNSATURATED FATTY ACID; VITAMIN K GROUP;

ADENOSINE DIPHOSPHATE RIBOSYLATION; APOPTOSIS; CELL FUNCTION; CELL PROLIFERATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; MOLECULAR DYNAMICS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SINGLE STRANDED DNA BREAK; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; HUMAN; METABOLISM; PHYSIOLOGY; POLY(ADENOSINE DIPHOSPHATE) RIBOSYLATION; DNA STRAND BREAKAGE; DRUG ACTIVITY; IONIZING RADIATION; PROTEIN MODIFICATION;

ANIMALS; HUMANS; OXIDATIVE STRESS; POLY (ADP-RIBOSE) POLYMERASE-1; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY ADP RIBOSYLATION;

EID: 84908607743     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.08.003     Document Type: Review

References (56)

1. Otto H., Reche P.A., et al. In silico characterization of the family of parp-like poly(ADP-ribosyl)transferases (pARTs). BMC Genomics 2005, 6:139. http://www.ncbi.nlm.nih.gov/pubmed/16202152, 10.1186/1471-2164-6-139.
2. Nishizuka Y., Ueda K., et al. Enzymic adenosine diphosphate ribosylation of histone and poly adenosine diphosphate ribose synthesis in rat liver nuclei. Journal of Biological Chemistry 1968, 243(13):3765-3767. http://www.ncbi.nlm.nih.gov/pubmed/4298073.
3. +-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 2004, 119(6):803-814. http://www.ncbi.nlm.nih.gov/pubmed/15607977, 10.1016/j.cell.2004.11.002.
4. Nosseri C., Coppola S., et al. Possible involvement of poly(ADP-ribosyl) polymerase in triggering stress-induced apoptosis. Experimental Cell Research 1994, 212(2):367-373. http://www.ncbi.nlm.nih.gov/pubmed/8187831, 10.1006/excr.1994.1156.
5. Juarez-Salinas H., Sims J.L., et al. Poly(ADP-ribose) levels in carcinogen-treated cells. Nature 1979, 282(5740):740-741. http://www.ncbi.nlm.nih.gov/pubmed/229416, 10.1038/282740a0.
6. Bürkle A., Virág L. Poly(ADP-ribose): PARadigms and PARadoxes. Molecular Aspects of Medicine 2013, 34(6):1046-1065. http://www.ncbi.nlm.nih.gov/pubmed/23290998, 10.1016/j.mam.2012.12.010.
7. Lonskaya I., Potaman V.N., et al. Regulation of poly(ADP-ribose) polymerase-1 by DNA structure-specific binding. Journal of Biological Chemistry 2005, 280(17):17076-17083. http://www.ncbi.nlm.nih.gov/pubmed/15737996, 10.1074/jbc.M413483200.
8. Pinnola A., Naumova N., et al. Nucleosomal core histones mediate dynamic regulation of poly(ADP-ribose) polymerase 1 protein binding to chromatin and induction of its enzymatic activity. Journal of Biological Chemistry 2007, 282(44):32511-32519. http://www.ncbi.nlm.nih.gov/pubmed/17827147, 10.1074/jbc.M705989200.
9. Cohen-Armon M. PARP-1 activation in the ERK signaling pathway. Trends in Pharmacological Sciences 2007, 28(11):556-560. http://www.ncbi.nlm.nih.gov/pubmed/17950909, 10.1016/j.tips.2007.08.005.
10. Cohen-Armon M., Visochek L., et al. DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Molecular Cell 2007, 25(2):297-308. http://www.ncbi.nlm.nih.gov/pubmed/17244536, 10.1016/j.molcel.2006.12.012.
11. Ju B.G., Solum D., et al. Activating the PARP-1 sensor component of the groucho/TLE1 corepressor complex mediates a CaMKinase IIdelta-dependent neurogenic gene activation pathway. Cell 2004, 119(6):815-829. http://www.ncbi.nlm.nih.gov/pubmed/15607978, 10.1016/j.cell.2004.11.017.
12. Van Meter M., Mao Z., et al. Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair. Aging 2011, 3(9):829-835. http://www.ncbi.nlm.nih.gov/pubmed/21946623.
13. Mao Z., Hine C., et al. SIRT6 promotes DNA repair under stress by activating PARP1. Science (New York, N.Y.) 2011, 332(6036):1443-1446. http://www.ncbi.nlm.nih.gov/pubmed/21680843, 10.1126/science.1202723.
14. Loseva O., Jemth A.S., et al. PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA. Journal of Biological Chemistry 2010, 285(11):8054-8060. http://www.ncbi.nlm.nih.gov/pubmed/20064938, 10.1074/jbc.M109.077834.
15. Rajamohan S.B., Pillai V.B., et al. SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1. Molecular and Cellular Biology 2009, 29(15):4116-4129. http://www.ncbi.nlm.nih.gov/pubmed/19470756, 10.1128/MCB.00121-09.
16. Gagné J.P., Moreel X., et al. Proteomic investigation of phosphorylation sites in poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase. Journal of Proteome Research 2009, 8(2):1014-1029. http://www.ncbi.nlm.nih.gov/pubmed/19105632, 10.1021/pr800810n.
17. Hassa P.O., Haenni S.S., et al. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. Journal of Biological Chemistry 2005, 280(49):40450-40464. http://www.ncbi.nlm.nih.gov/pubmed/16204234, 10.1074/jbc.M507553200.
18. Banasik M., Komura H., et al. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. Journal of Biological Chemistry 1992, 267(3):1569-1575. http://www.ncbi.nlm.nih.gov/pubmed/1530940.
19. Virág L., Szabó C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacological Reviews 2002, 54(3):375-429. http://www.ncbi.nlm.nih.gov/pubmed/12223530, 10.1124/pr.54.3.375.
20. Jagtap P., Szabó C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nature Reviews: Drug Discovery 2005, 4(5):421-440. http://www.ncbi.nlm.nih.gov/pubmed/15864271, 10.1038/nrd1718.
21. Banasik M., Komura H., et al. Inhibition of poly(ADP-ribose) synthetase by unsaturated fatty acids, vitamins and vitamin-like substances. FEBS Letters 1990, 263(2):222-224. http://www.ncbi.nlm.nih.gov/pubmed/2139856, 10.1016/0014-5793(90)81378-2.
22. Banasik M., Stedeford T., et al. Natural inhibitors of poly(ADP-ribose) polymerase-1. Molecular Neurobiology 2012, 46(1):55-63. http://www.ncbi.nlm.nih.gov/pubmed/22476980, 10.1007/s12035-012-8257-x.
23. Yager J.W., Wiencke J.K. Inhibition of poly(ADP-ribose) polymerase by arsenite. Mutation Research 1997, 386(3):345-351. http://www.ncbi.nlm.nih.gov/pubmed/9219571, 10.1016/S1383-5742(97)00011-2.
24. Alano C.C., Kauppinen T.M., et al. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(25):9685-9690. http://www.ncbi.nlm.nih.gov/pubmed/16769901, 10.1073/pnas.0600554103.
25. Geraets L., Moonen H.J., et al. Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. Journal of Nutrition 2007, 137(10):2190-2195. http://www.ncbi.nlm.nih.gov/pubmed/17884996.
26. Virág L., Szabó C. Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2001, 15(1):99-107. http://www.ncbi.nlm.nih.gov/pubmed/11149897, 10.1096/fj.00-0299com.
27. Mabley J.G., Wallace R., et al. Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D. International Journal of Molecular Medicine 2007, 19(6):947-952. http://www.ncbi.nlm.nih.gov/pubmed/17487428.
28. Ariumi Y., Masutani M., et al. Suppression of the poly(ADP-ribose) polymerase activity by DNA-dependent protein kinase in vitro. Oncogene 1999, 18(32):4616-4625. http://www.ncbi.nlm.nih.gov/pubmed/10467406, 10.1038/sj.onc.1202823.
29. Tanaka Y., Koide S.S., et al. Poly (ADP-ribose) synthetase is phosphorylated by protein kinase C in vitro. Biochemical and Biophysical Research Communications 1987, 148(2):709-717. http://www.ncbi.nlm.nih.gov/pubmed/3120711, 10.1016/0006-291X(87)90934-X.
30. Bauer P.I., Farkas G., et al. Inhibition of DNA binding by the phosphorylation of poly ADP-ribose polymerase protein catalysed by protein kinase C. Biochemical and Biophysical Research Communications 1992, 187(2):730-736. http://www.ncbi.nlm.nih.gov/pubmed/1530631, 10.1016/0006-291X(92)91256-P.
31. Hegedus C., Lakatos P., et al. Protein kinase C protects from DNA damage-induced necrotic cell death by inhibiting poly(ADP-ribose) polymerase-1. FEBS Letters 2008, 582(12):1672-1678. http://www.ncbi.nlm.nih.gov/pubmed/18439913, 10.1016/j.febslet.2008.04.023.
32. Viráģ L., Scott G.S., et al. Requirement of intracellular calcium mobilization for peroxynitrite-induced poly(ADP-ribose) synthetase activation and cytotoxicity. Molecular Pharmacology 1999, 56(4):824-833. http://www.ncbi.nlm.nih.gov/pubmed/10496967.
33. Bakondi E., Gönczi M., et al. Role of intracellular calcium mobilization and cell-density-dependent signaling in oxidative-stress-induced cytotoxicity in HaCaT keratinocytes. Journal of Investigative Dermatology 2003, 121(1):88-95. http://www.ncbi.nlm.nih.gov/pubmed/12839568, 10.1046/j.1523-1747.2003.12329.x.
34. 2+, histones H1 and H3, and ATP. Biochemistry 2004, 43(1):210-216. http://www.ncbi.nlm.nih.gov/pubmed/14705947, 10.1021/bi0301791.
35. Virág L., Scott G.S., et al. Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly(ADP-ribose) synthetase (PARS) activation. Immunology 1998, 94(3):345-355. http://www.ncbi.nlm.nih.gov/pubmed/9767416, 10.1046/j.1365-2567.1998.00534.x.
36. Chaigne-Delalande B., Lenardo M.J. Divalent cation signaling in immune cells. Trends in Immunology 2014, 35(7):332-344. http://www.ncbi.nlm.nih.gov/pubmed/24932518, 10.1016/j.it.2014.05.001.
37. Virág L., Szabó C. Inhibition of poly(ADP-ribose) synthetase (PARS) and protection against peroxynitrite-induced cytotoxicity by zinc chelation. British Journal of Pharmacology 1999, 126(3):769-777. http://www.ncbi.nlm.nih.gov/pubmed/10188990, 10.1038/sj.bjp.0702332.
38. Ungerstedt J.S., Blömback M., et al. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clinical and Experimental Immunology 2003, 131(1):48-52. http://www.ncbi.nlm.nih.gov/pubmed/12519385.
39. Kraus W.L., Lis J.T. PARP goes transcription. Cell 2003, 113(6):677-683. http://www.ncbi.nlm.nih.gov/pubmed/12809599, 10.1016/S0092-8674(03)00433-1.
40. Kraus W.L., Hottiger M.O. PARP-1 and gene regulation: Progress and puzzles. Molecular Aspects of Medicine 2013, 34(6):1109-1123. http://www.ncbi.nlm.nih.gov/pubmed/23357755, 10.1016/j.mam.2013.01.005.
41. Dantzer F., Nasheuer H.P., et al. Functional association of poly(ADP-ribose) polymerase with DNA polymerase alpha-primase complex: a link between DNA strand break detection and DNA replication. Nucleic Acids Research 1998, 26(8):1891-1898. http://www.ncbi.nlm.nih.gov/pubmed/9518481, 10.1093/nar/26.8.1891.
42. de Murcia G., Ménissier de Murcia J. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends in Biochemical Sciences 1994, 19(4):172-176. http://www.ncbi.nlm.nih.gov/pubmed/8016868.
43. Ménisser-de Murcia J., Mark M., et al. Early embryonic lethality in PARP-1 Atm double-mutant mice suggests a functional synergy in cell proliferation during development. Molecular and Cellular Biology 2001, 21(5):1828-1832. http://www.ncbi.nlm.nih.gov/pubmed/11238919, 10.1128/MCB.21.5.1828-1832.2001.
44. Bhatia M., Kirkland J.B., et al. Modulation of poly(ADP-ribose) polymerase during neutrophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leukaemia cells. Biochemical Journal 1995, 308(1):131-137. http://www.ncbi.nlm.nih.gov/pubmed/7755555.
45. Masutani M., Nozaki T., et al. Involvement of poly(ADP-ribose) polymerase in trophoblastic cell differentiation during tumorigenesis. Mutation Research 2001, 477(1-2):111-117. http://www.ncbi.nlm.nih.gov/pubmed/11376692.
46. Robaszkiewicz A., Erdélyi K., et al. Hydrogen peroxide-induced poly(ADP-ribosyl)ation regulates osteogenic differentiation-associated cell death. Free Radical Biology and Medicine 2012, 53(8):1552-1564. http://www.ncbi.nlm.nih.gov/pubmed/22940495, 10.1016/j.freeradbiomed.2012.08.567.
47. Robaszkiewicz A., Valkó Z., et al. The role of p38 signaling and poly(ADP-ribosyl)ation-induced metabolic collapse in osteogenic differentiation-coupled cell death. Free Radical Biology and Medicine 2014, 10.1016/j.freeradbiomed.2014.07.027.
48. Berger N.A., Sims J.L., et al. Poly(ADP-ribose) polymerase mediates the suicide response to massive DNA damage: Studies in normal and DNA-repair defective cells. Princess Takamatsu Symposia 1983, 13:219-226. http://www.ncbi.nlm.nih.gov/pubmed/6317637.
49. Virág L., Marmer D.J., et al. Crucial role of apopain in the peroxynitrite-induced apoptotic DNA fragmentation. Free Radical Biology and Medicine 1998, 25(9):1075-1082. http://www.ncbi.nlm.nih.gov/pubmed/9870561, 10.1016/S0891-5849(98)00139-7.
50. Virág L., Salzman A.L., et al. Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. Journal of Immunology (Baltimore, Md.: 1950) 1998, 161(7):3753-3759. http://www.ncbi.nlm.nih.gov/pubmed/9759901.
51. Hassa P.O., Hottiger M.O. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Frontiers in Bioscience: A Journal and Virtual Library 2008, 13:3046-3082. http://www.ncbi.nlm.nih.gov/pubmed/17981777, 10.2741/2909.
52. Yu S.W., Wang H., et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science (New York, N.Y.) 2002, 297(5579):259-263. http://www.ncbi.nlm.nih.gov/pubmed/12114629, 10.1126/science.1072221.
53. Virág L., Robaszkiewicz A., et al. Poly(ADP-ribose) signaling in cell death. Molecular Aspects of Medicine 2013, 34(6):1153-1167. http://www.ncbi.nlm.nih.gov/pubmed/23416893, 10.1016/j.mam.2013.01.007.
54. Scott G.S., Hake P., et al. Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis. Journal of Neuroimmunology 2001, 117(1-2):78-86. http://www.ncbi.nlm.nih.gov/pubmed/11431007, 10.1016/S0165-5728(01)00329-0.
55. Virág L. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Current Vascular Pharmacology 2005, 3(3):209-214. http://www.ncbi.nlm.nih.gov/pubmed/16026317, 10.2174/1570161054368625.
56. Andrabi S.A., Umanah G.K., et al. Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proceedings of the National Academy of Sciences of the United States of America 2014, 111(28):10209-10214. http://www.ncbi.nlm.nih.gov/pubmed/24987120, 10.1073/pnas.1405158111.